Cargando…
Medication-related osteonecrosis of the jaw after dental clearance: Prevalence in an oncology center
OBJECTIVE: Medication-related osteonecrosis of the jaw (MRONJ), a complication of bisphosphonate therapy, has significant morbidity. This study aimed to determine the prevalence of MRONJ and compare its risks among patients who received antiresorptive or antiangiogenic therapy in King Fahad Medical...
Autores principales: | Hajeri, Saad, Alturkistany, Yasir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9453503/ https://www.ncbi.nlm.nih.gov/pubmed/36092518 http://dx.doi.org/10.1016/j.sdentj.2022.06.004 |
Ejemplares similares
-
Dental students' knowledge of medication-related osteonecrosis of the jaw
por: Rosella, Daniele, et al.
Publicado: (2017) -
Dental practitioners' and students' knowledge of medication related osteonecrosis of the jaw (MRONJ)
por: Almousa, Mandlin Abdulaziz, et al.
Publicado: (2021) -
Bisphosphonate-related osteonecrosis of the jaw and dental implants
por: Qamheya, Ala Hassan A., et al.
Publicado: (2016) -
Medication-related osteonecrosis of the jaw: An update
por: Bansal, Hitesh
Publicado: (2022) -
Update on Medication Related Osteonecrosis of the Jaws
por: Boyd, Barry C.
Publicado: (2023)